Researchers in Tayside are looking for people with COPD to take part in a study. It will test a new drug called Astegolimab, to see if it reduces COPD symptoms and flare-ups.

In this study, one third of people will receive the study drug Astegolimab, one third will receive a placebo, and the last third will receive both the drug and placebo on alternating visits. This would be in addition to your normal COPD medication.

The study will last for approximately 1 year, with visits to Ninewells hospital to receive an injection of the study drug or the placebo, every 2 weeks. You will also be asked to keep a daily diary on an electronic device given to you by the hospital.

If you agree to take part, you will have some lung function tests, provide blood samples and have some physical examinations at Ninewells hospital before the study begins.

If you would like to take part in this study, please get in touch with the SHARE Studies Team by telephone on 01382 383235 or email at [email protected] and we can tell you more about the study.

Also, If this study is not suitable for you, please register for SHARE so that we can let you know about other studies which may be relevant to you Register now